Related references
Note: Only part of the references are listed.Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Takashi Yamamura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis
Kenichi Serizawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Antibodies to watch in 2017
Janice M. Reichert
MABS (2017)
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption
Tomohiko Uchida et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption
Tomohiko Uchida et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica
Fumitaka Shimizu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus
Tomoyuki Asano et al.
PLOS ONE (2017)
Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro
Yukio Takeshita et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Clinical utility of testing AQP4-IgG in CSF Guidance for physicians
Masoud Majed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Targeting interleukin-6 for noninfectious uveitis
Phoebe Lin
CLINICAL OPHTHALMOLOGY (2015)
An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture
Yukio Takeshita et al.
JOURNAL OF NEUROSCIENCE METHODS (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions
Keith D. Rochfort et al.
PLOS ONE (2014)
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
Anu Jacob et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement
Hiroyo Haruki et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Development, maintenance and disruption of the blood-brain barrier
Birgit Obermeier et al.
NATURE MEDICINE (2013)
Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro
Fumitaka Shimizu et al.
NEUROBIOLOGY OF AGING (2013)
Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
Takuya Matsushita et al.
PLOS ONE (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models
Yukio Takeshita et al.
IMMUNOLOGICAL REVIEWS (2012)
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability
Y. Tomizawa et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Sera from neuromyelitis optica patients disrupt the blood-brain barrier
Fumitaka Shimizu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Aquaporin 4 and neuromyelitis optica
Marios C. Papadopoulos et al.
LANCET NEUROLOGY (2012)
CXCL12-Induced Monocyte-Endothelial Interactions Promote Lymphocyte Transmigration Across an in Vitro Blood-Brain Barrier
Shumei Man et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Hua Zhang et al.
ANNALS OF NEUROLOGY (2011)
Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood-brain barrier
Takafumi Hosokawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Establishment of a New Conditionally Immortalized Human Brain Microvascular Endothelial Cell Line Retaining an In Vivo Blood-Brain Barrier Function
Yasuteru Sano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Akiyuki Uzawa et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
Tomoyuki Igawa et al.
NATURE BIOTECHNOLOGY (2010)
Reduced elimination of IgG antibodies by engineering the variable region
T. Igawa et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY (2009)
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
Takeru Yoshimura et al.
RHEUMATOLOGY (2009)
Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells
Fumitaka Shimizu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Characterization of anti-mouse interleukin-6 receptor antibody
M Okazaki et al.
IMMUNOLOGY LETTERS (2002)
Share Paper
